Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Alinari · SciRah

Researcher profile · Semantic Scholar

L. Alinari

Share profile

L. Alinari — researcher profile on SciRah

h-index: 41
Works: 228
Citations: 5,205

Most-cited papers

VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia
S. Sher, E. Whipp, J. Walker, Pu Zhang +22 more
2022Leukemia30 citations Open access
Semantic Scholar
PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma.
S. Sloan, F. Brown, Mackenzie E Long, C. Weigel +27 more
2023Blood27 citations Open access
Semantic Scholar
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation
Zachary A. Hing, J. Walker, E. Whipp, Lindsey T Brinton +37 more
2023Nature Communications25 citations Open access
Semantic Scholar
Targeting OXPHOS de novo purine synthesis as the nexus of FLT3 inhibitor–mediated synergistic antileukemic actions
Pu Zhang, Lindsey T Brinton, Mehdi Gharghabi, S. Sher +19 more
2022Science Advances22 citations Open access
Semantic Scholar
A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models
W. Chan, Jessica F. Williams, Kinnari Sorathia, Betsy A Pray +16 more
2023Experimental Hematology & Oncology21 citations Open access
Semantic Scholar
TBL1X: AT THE CROSSROADS OF TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL REGULATION
Betsy A Pray, Y. Youssef, L. Alinari
2022Experimental Hematology19 citations Open access
Semantic Scholar
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma
Fiona Brown-Burke, I. Hwang, S. Sloan, C. Hinterschied +20 more
2023Blood Advances16 citations Open access
Semantic Scholar
Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies
E. Umyarova, Charles Pei, William Pellegrino, Qiuhong Zhao +27 more
2025Journal of Hematology & Oncology15 citations Open access
Semantic Scholar
A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas
Ja-Young Jang, I. Hwang, H. Pan, Jun Yao +20 more
2022Journal of Clinical Investigation15 citations Open access
Semantic Scholar
T cell-intrinsic immunomodulatory effects of TAK-981 (subasumstat), a SUMO-activating enzyme inhibitor, in chronic lymphocytic leukemia
Vi Lam, Carly Roleder, Tingting Liu, Nur Bruss +10 more
2023Molecular Cancer Therapeutics14 citations Open access
Semantic Scholar
Phase I/II Study of Subasumstat (TAK-981) in Combination With Rituximab in Relapsed/Refractory Non-Hodgkin Lymphoma.
S. Assouline, Amitkumar Mehta, W. Hanel, Stéphane Doucet +9 more
2025Clinical Lymphoma, Myeloma & Leukemia12 citations Open access
Semantic Scholar
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma
N. Denlinger, No-Joon Song, Xiaoli Zhang, H. Jeon +30 more
2024Blood Advances12 citations Open access
Semantic Scholar
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma
A. Sircar, S. Singh, Zijun Y. Xu-Monette, K. Coyle +15 more
2023Leukemia12 citations Open access
Semantic Scholar
Resistance to PRMT5-targeted therapy in mantle cell lymphoma
Mackenzie E Long, Shirshak Koirala, S. Sloan, Fiona Brown-Burke +20 more
2023Blood Advances10 citations Open access
Semantic Scholar
Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein–Barr Virus Lymphoproliferative Disorder
E. Ahmed, Mark E. Lustberg, Claire Hale, S. Sloan +19 more
2023Cancers10 citations Open access
Semantic Scholar
TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environment
Pu Zhang, E. Whipp, Sarah J. Skuli, Mehdi Gharghabi +39 more
2025Journal of Clinical Investigation8 citations Open access
Semantic Scholar
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells
W. Hanel, Pushpa Lata, Y. Youssef, H. Tran +16 more
2022Experimental Hematology & Oncology8 citations Open access
Semantic Scholar
Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective study
Megan K Fleming, Ying Huang, Emily K. Dotson, D. Bond +8 more
2021Therapeutic Advances in Hematology8 citations Open access
Semantic Scholar
A Phase I Clinical Trial of Point-of-Care Manufactured Fresh Anti-CD19/20/22 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Lymphoid Malignancies (Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, B Prolymphocytic Leukemia)
S. Vasu, L. Alinari, Nicole Szuminski, D. Schneider +9 more
2022Blood6 citations Open access
Semantic Scholar
Siltuximab Prophylaxis Prior to Standard of Care CD19 Directed Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphomas: Interim Results from a Phase I Clinical Trial
T. Voorhees, Ying Huang, N. Denlinger, N. Epperla +16 more
2024Transplantation and Cellular Therapy5 citations Open access
Semantic Scholar
Treatment of primary mediastinal B-cell lymphoma with dose-adjusted REPOCH during pregnancy
K. Annunzio, M. Cackovic, D. Bond, Y. Sawalha +9 more
2022Blood Advances5 citations Open access
Semantic Scholar
SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma
R. P. Dutta, Heng-Huan Lee, V. Leshchenko, R. P. Shukla +8 more
2025Blood Advances4 citations Open access
Semantic Scholar
Resistance Mechanism for Zanubrutinib in Marginal Zone Lymphoma.
J. Sharp, A. Shanaah, T. Voorhees, D. Bond +10 more
2025The Journal of the National Comprehensive Cancer Network4 citations
Semantic Scholar
Initial Results of a First-in-Human, Phase I Study Point-of-Care Manufacturing of Trispecific CAR-T Cells Targeting CD19/20/22 in B-Cell Malignancies
S. Vasu, Evandro D. Bezerra, N. Denlinger, Nicole Szuminski +17 more
2024Blood4 citations
Semantic Scholar
Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents
M. Faisal, W. Hanel, T. Voorhees, Rui Li +16 more
2023Cancer Medicine4 citations Open access
Semantic Scholar
Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease
C. Weigel, H. Klimaszewski, Fode Tounkara, S. Addissie +17 more
2026Blood neoplasia3 citations Open access
Semantic Scholar
Association between post-CART terminal complement complex (TCC) levels and clinically significant immune effector cell–associated neurotoxicity syndrome (ICANS).
George Iii, Qiu-Hong Zhao, T. Voorhees, N. Denlinger +16 more
2024Journal of Clinical Oncology3 citations Open access
Semantic Scholar
Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma
Imani Bijou, Yang Liu, Dong Lu, Jing Chen +6 more
2023Research Square3 citations Open access
Semantic Scholar
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma
S. Chowdhury, Subodh Bhatta, T. Voorhees, K. Annunzio +11 more
2025Journal of Hematology & Oncology2 citations
Semantic Scholar
Acute kidney injury after chimeric antigen receptor T‐cell therapy is associated with inferior survival in patients with relapsed/refractory large B‐cell lymphoma
J. Sharp, Qiuhong Zhao, T. Voorhees, D. Bond +16 more
2025British Journal of Haematology2 citations Open access
Semantic Scholar
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia
A. Nalin, Qiuhong Zhao, T. Voorhees, D. Bond +10 more
2023Frontiers in Oncology2 citations Open access
Semantic Scholar
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
D. Bond, L. Wei, V. Yildiz, J. Reneau +19 more
2023Hematological Oncology2 citations Open access
Semantic Scholar
PRMT5 Inhibition Modulates E2F1 and P53 to Restore Cell Cycle Regulation and Drive DNA Damage Response in Ibrutinib-Resistant Mantle Cell Lymphoma
S. Sloan, F. Brown, Mackenzie E Long, J. Helmig-Mason +17 more
2021Blood2 citations Open access
Semantic Scholar
Targeting the DNA damage response through TBL1X in mantle cell lymphoma
Betsy A Pray, E. Baiocchi, Sydney Leon, Brian Barta +15 more
2025Blood Advances1 citations Open access
Semantic Scholar
Steroid Prophylaxis in Patients Receiving CAR T-Cell Therapy for Relapsed and Refractory Non-Hodgkin Lymphoma
Jacob Butman, Alma Habib, R. Welkie, Y. Sawalha +17 more
2025Transplantation and Cellular Therapy1 citations Open access
Semantic Scholar
Histone demethylases KDM5A/B regulate epigenetic programming of exhausted T cells and restrain immunotherapy responses 4207
Amira Yousif, Abbey A. Saadey, Ava Lowin, Wing Chan +6 more
2025Journal of Immunology1 citations
Semantic Scholar
Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment Resistance
S. Hwang, Helgi Nikolli, B. Yoval-Sánchez, Sieun Yang +13 more
2025bioRxiv1 citations
Semantic Scholar
The novel immunocompetent Eμ-SOX11CCND1 mouse model phenotypically and molecularly resembles human mantle cell lymphoma
Hedieh Jafari, Fiona Brown-Burke, Betsy A Pray, S. Sloan +25 more
2025Clinical Cancer Research1 citations
Semantic Scholar
PRMT5 inhibition reduces hyperinflammation in a murine model of secondary hemophagocytic lymphohistiocytosis
Fiona Brown-Burke, Rachel Saadey, H. Mao, Paola Marra +32 more
2025Blood Advances1 citations Open access
Semantic Scholar
Modulating the epigenetic interplay in exhausted CD8 T cells for effective immunotherapy
Amira Yousif, Abbey A. Saadey, Ava Lowin, Chelsea Castillo +6 more
2024Journal of Immunology1 citations
Semantic Scholar
Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy Is Associated with Inferior Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma
J. Sharp, Qiuhong Zhao, T. Voorhees, D. Bond +16 more
2024Blood1 citations
Semantic Scholar
Steroid Prophylaxis in Patients Receiving CAR T-Cell Therapy for Relapsed and Refractory Non-Hodgkin Lymphoma
Jacob Butman, Alma Habib, R. Welkie, Y. Sawalha +17 more
2024Blood1 citations
Semantic Scholar
Zanubrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): Interim Results from a Phase 1b Clinical Trial
Y. Sawalha, R. Welkie, Anna Krivenko, B. Hess +11 more
2023Blood1 citations Open access
Semantic Scholar
Acquired Resistance to PRMT5 Inhibition in Mantle Cell Lymphoma Is Associated with Compensatory Activation of Multiple Signaling Pathways
Mackenzie E Long, Shirshak Koirala, S. Sloan, F. Brown +14 more
2022Blood1 citations Open access
Semantic Scholar
Abstract 3057: Selective targeting of sumoylation disrupts mitochondrial homeostasis via TRAP1 to suppress growth of non-Hodgkin lymphoma (NHL) B-cells
V. Lam, Ting-Ting Liu, Hei-Feng Shen, Olga Danilova +11 more
2026Cancer Research0 citations
Semantic Scholar
Abstract 4490: PRMT5 inhibition alters cellular chromatin landscape and drives vulnerability to BH3 mimetics in mantle cell lymphoma.
C. Weigel, C. Hinterschied, Shirshak Koirala, Mackenzie E Long +23 more
2026Cancer Research0 citations
Semantic Scholar
Spatial tissue analysis of secondary sarcoma following CAR T cell therapy for B cell lymphoma
Jia-Jye Lee, Pei-Rong Hu, Kun Luo, Jinling Wang +16 more
2026iScience0 citations Open access
Semantic Scholar
Decoding Histone-DNA Methylation Crosstalk in Exhausted T Cells to Enhance Immunotherapy 2253691
Hazem E. Ghoneim, Amira Yousif, Abbey A. Saadey, Ava Lowin +6 more
2026Journal of Immunology0 citations Open access
Semantic Scholar
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22
S. Vasu, N. Denlinger, No-Joon Song, D. Elsberry +29 more
2026Research Square0 citations Open access
Semantic Scholar
Impact of Prophylactic Steroids on CAR T-cell Related Toxicity for Relapsed and Refractory Non-Hodgkin Lymphoma.
Alma Habib, Youssef Youssef, R. Welkie, Jacob Butman +24 more
2026Transplantation and Cellular Therapy0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

W. Hanel×23
Invite
W. Hanel — researcher profile on SciRah
R. Baiocchi×19
Invite
R. Baiocchi — researcher profile on SciRah
Y. Sawalha×19
Invite
Y. Sawalha — researcher profile on SciRah
K. Maddocks×18
Invite
K. Maddocks — researcher profile on SciRah

×18

Invite

T. Voorhees — researcher profile on SciRah

Invite

D. Bond — researcher profile on SciRah

N. Denlinger×15

Invite

N. Denlinger — researcher profile on SciRah

Invite

S. Vasu — researcher profile on SciRah

M. D. De Lima×14

Invite

M. D. De Lima — researcher profile on SciRah

Invite

N. Epperla — researcher profile on SciRah

Invite

J. Reneau — researcher profile on SciRah

Invite

L. Sehgal — researcher profile on SciRah